AzTrials
AzTrials

Tinnitus, SubjectiveNCT04310605

Effectiveness of Specialised Cognitive Behavioural Therapy (CBT) for Tinnitus.

An observational study of Tinnitus, Subjective, run by Maastricht University.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This is an observational study of specialised CBT for tinnitus for adults delivered in routine care. Read more about this study

Who is it for?
Ages 17 years and older
Conditions the study is for
Tinnitus, Subjective
What is being tested?
CBT 1 and CBT 2
How many people
403 participants
Where
No sites listed yet
Study dates
1 Jan 2014to 16 Nov 2016
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 17 years and older
  • All sexes
  • Child, Adult, Older adult

Study population: Adults with tinnitus

Who may be able to join

  • Tinnitus is the primary complaint and reason for seeking help
  • Participant is at least 17 years of age,

Who cannot join

  • Unable to read and write in Dutch
  • Tinnitus is not the primary complaint
  • Person is under 17 years of age
  • Participant has a health condition that prevents them from attending treatment centre
  • An Ear Nose Throat (ENT) physician assesses the participant as having ontological condition that requires medical treatment

About this study

Official title: Cognitive Behaviour Therapy (CBT) for Tinnitus Treatment: Implementation and Validity

This is an observational study of specialised CBT for tinnitus for adults delivered in routine care.

Being tested
CBT 1, CBT 2
Keywords
tinnitus, CBT, cognitive behaviour therapy
Medical subject headings
Tinnitus

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • CBT 1Behavioural

    CBT for tinnitus (Step 1) comprised: individual audiometric assessment, and counselling about hearing and tinnitus (1hr) with an audiologist; a one-off educational group session (a max 10 participants and partners) (2hrs); an assessment session with a psychologists (1 hr).

  • CBT 2Behavioural

    Step 2 group sessions were 2 hrs long over a 12-week period. Two therapists (a psychologist and physiotherapist) were present at any one time for Step 2 sessions. Step 2 included: psycho-education; exposure therapy; mindfulness exercises; cognitive restructuring; attention redirecting techniques; stress reduction; and, relaxation techniques. Evening sessions were also provided for participants to attend with family or partners.

Study groups in NCT04310605
Study groupRoleWhat they receive
Step 1 onlyParticipants in the study who only receive Step 1 of specialised CBT
Receives: Behavioral: CBT 1
Step 1 and 2Participants who receive both Step 1 and Step 2 of speciliased CBT for tinnitus.
Receives: Behavioral: CBT 1; Behavioral: CBT 2

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Health Utilities Index-III

    The Health Utilities Index (HUI; Feeny et al., 2002; Horsman, Furlong, Feeny, \& Torrance, 2003) is a 17-item measure designed to assess health related quality of life.

    Measured: 12 months

Secondary outcomes (6)
  1. Tinnitus Handicap Inventory (THI)

    The THI (Newman, Jacobson, \& Spitzer, 1996; Newman, Sandridge, \& Jacobson, 1998).is a 25 items measure of the impact of tinnitus on daily life that includes three subscales. The subscales cover functional (mental, social/occupational and physical functioning), emotional impact and catastrophic responses to tinnitus.

    Measured: 12 months

  2. Hospital Anxiety and Depression Scale (HADS; Zigmond & Snaith, 1983).

    The HADS is a widely used measure of psychological distress in people experiencing a concurrent physical health condition. It has 14 items and respondents use a Likert-type scale to indicate how often they have had a particular feeling in the previous week (e.g. "I feel tense or wound up").

    Measured: 12 months

  3. Tinnitus Catastrophizing Scale (TCS)

    Tinnitus Catastrophizing Scale (TCS; Cima, Crombez, \& Vlaeyen, 2011). The TCS was used to assess the degree to which people thought or expected the worst about tinnitus (i.e. catastrophizing). The TCS is a 13-item measure based on the Pain Catastrophizing Scale (Sullivan, Bishop, \& Pivik, 1995) and respondents use a five point scale to indicate the degree to which statements applies to them (e.g. It's terrible and I think it's never going to get any better). The total score on the TCS ranges from 0 to 65.

    Measured: 12 months

  4. Fear of Tinnitus Questionnaire (FTQ)

    The FTQ is a 17-item self-report measure intended and designed to assess respondents' level of fear regarding their tinnitus. Items in the questionnaire are presented as a series of statements (e.g. "I am afraid that my tinnitus will become worse") from which respondents are asked to indicate if it is applicable to their current situation. Each statement receives a score of 1 when applicable. The total score is the sum of all applicable statements and provides an overall rating of fear of tinnitus and ranges from 0 to 17.

    Measured: 12 months

  5. Tinnitus Questionnaire (TQ)

    The Tinnitus Questionnaire (TQ; Hallam, Jakes, \& Hinchcliffe, 1988) is a self-report questionnaire designed to asses distress and interference in daily activities that is associated with tinnitus. It has 52 items and uses a three-point scale to indicate levels of distress on six subscales. The total possible score on the TQ ranges from 0-84.

    Measured: 12 months

  6. Tinnitus Disability Index (TDI)

    The Tinnitus Disability Index (TDI; Cima, Vlaeyen, Maes, Joore, \& Anteunis, 2011) is a seven-item self-report questionnaire that assesses the level of interferences in daily activities (such as occupational, social, and recreational) attributed to tinnitus. Respondents use an 11-point scale to indicate the level of interference ranging from 0 no disability, to 10 total disability. The total score ranges from 0 to 70 with higher scores indicating higher levels of interference.

    Measured: 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Mar 2020
  2. Study start1 Jan 2014
  3. Primary completion16 Nov 2016
  4. Study completion16 Nov 2016

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
403 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04310605
Sponsor's protocol ID
ECP-152 05_12_2014
Status last verified
Mar 2020
First submitted
13 Mar 2020
Last updated
17 Mar 2020
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • Cima RF, Maes IH, Joore MA, Scheyen DJ, El Refaie A, Baguley DM, Anteunis LJ, van Breukelen GJ, Vlaeyen JW. Specialised treatment based on cognitive behaviour therapy versus usual care for tinnitus: a randomised controlled trial. Lancet. 2012 May 26;379(9830):1951-9. doi: 10.1016/S0140-6736(12)60469-3.

    PubMed 22633033

Questions about this trial

What is this clinical trial studying?

An observational study of Tinnitus, Subjective, run by Maastricht University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 17 Mar 2020. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Health Utilities Index-III (time frame: 12 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04310605, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Mar 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in